Skip to main content
. 2023 Mar 30;15(7):2055. doi: 10.3390/cancers15072055

Table 1.

The general characteristics of studies included in this article. RCT, randomized controlled trial; KTP laser, Potassium-Titanyl-Phosphate laser; N/A, not available.

First Author Year Study Design Surgical Method Number of Patients Male/Female Mean Age Adjuvant Therapy
ERBT ERBT CTURBT ERBT CTURBT ERBT CTURBT
Zhu et al. [9] 2008 Retrospective Holmium laser 101 111 79/22 92/19 N/A N/A Mitomycin
Song1 et al. [10] 2010 Retrospective Holmium laser 64 51 52/12 40/11 72.50 74.50 Mitomycin
Song2 et al. [10] 2010 Retrospective Holmium laser 64 58 52/12 47/11 72.50 73.00 Mitomycin
Zhong1 et al. [11] 2010 Retrospective Thulium laser 30 42 N/A N/A 68.30 66.26 Epirubicin
Zhong2 et al. [11] 2010 Retrospective Holmium laser 25 42 N/A N/A 65.76 66.26 Epirubicin
Upadhyay [12] 2012 Prospective Monopolar 21 25 N/A N/A N/A N/A N/A
Liu et al. [13] 2013 RCT Thulium laser 64 56 46/18 40/16 67.10 66.30 Epirubicin
Tao et al. [14] 2013 Retrospective KTP laser 74 84 60/14 66/18 66.4 65.3 Epirubicin
Sureka [15] 2014 Prospective Monopolar 21 24 N/A N/A 52.6 55 BCG
Yang et al. [16] 2014 Retrospective KTP laser 28 32 22/6 25/7 45.3 42.5 Epirubicin
Chen et al. [17] 2015 RCT Thulium laser 71 71 54/17 51/20 63 62 Epirubicin
Xu et al. [18] 2015 RCT KTP laser 99 94 80/19 76/18 63.06 62.82 Pirarubicin
Zhang et al. [19] 2015 RCT Thulium laser 149 143 70/79 79/64 N/A N/A Epirubicin
Chen et al. [20] 2016 Prospective KTP laser 83 75 60/23 51/24 63.43 65.31 Mitomycin
D’souza [21] 2016 Prospective Holmium laser 23 27 15/8 18/9 66.3 67.1 Mitomycin
Huang1 [22] 2016 Retrospective Thulium laser 70 70 50/20 48/22 58.31 57.87 Epirubicin
Huang2 et al. [22] 2016 Retrospective Holmium laser 70 70 45/25 48/22 59.97 57.87 Epirubicin
Cheng et al. [23] 2017 Retrospective KTP laser 34 30 28/6 27/3 59.41 63.13 Mitomycin
Zhang et al. [24] 2017 Retrospective Monopolar 40 50 35/5 38/12 60.65 60.8 Pirarubicin
Xu et al. [25] 2018 Retrospective Thulium laser 26 44 24/2 35/9 55.9 59.7 Pirarubicin
Bălan et al. [26] 2018 Prospective Bipolar 45 45 N/A N/A 64.7 66.1 BCG + Epirubicin
Cheng et al. [27] 2018 Retrospective Hybrid knife 95 98 67/28 70/28 62.4 64.4 Pirarubicin
Li et al. [28] 2018 Retrospective Thulium laser 136 120 110/26 98/22 N/A N/A Pirarubicin
Liang et al. [29] 2019 Retrospective KTP laser 88 70 78/10 51/19 N/A N/A Pirarubicin
Bangash [30] 2020 Prospective Monopolar 41 41 34/7 36/5 58.46 58.59 Mitomycin
Gakis et al. [31] 2020 RCT Hybrid knife 56 59 45/11 47/12 66.8 70.2 N/A
Hashem [32] 2020 RCT Holmium laser 50 50 37/13 39/11 60.4 61.1 Epirubicin
Vladanov [33] 2020 Retrospective Monopolar 67 85 57/10 66/19 58.43 61.5 Mitomycin
Yang et al. [34] 2020 Prospective Monopolar 96 87 70/26 62/25 54.63 55.43 Pirarubicin
Poletajew et al. [35] 2021 Prospective Monopolar 153 274 117/36 201/63 68 69.5 N/A
Tripathi et al. [36] 2021 Prospective KTP laser 40 43 32/8 30/13 55.62 56.12 Mitomycin